Digital Aria Co Ltd (115450) - Net Assets

Latest as of December 2025: ₩173.86 Billion KRW ≈ $117.82 Million USD

Based on the latest financial reports, Digital Aria Co Ltd (115450) has net assets worth ₩173.86 Billion KRW (≈ $117.82 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩228.66 Billion ≈ $154.96 Million USD) and total liabilities (₩54.79 Billion ≈ $37.13 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 115450 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩173.86 Billion
% of Total Assets 76.04%
Annual Growth Rate 17.41%
5-Year Change 46.5%
10-Year Change 413.19%
Growth Volatility 38.17

Digital Aria Co Ltd - Net Assets Trend (2011–2025)

This chart illustrates how Digital Aria Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Digital Aria Co Ltd assets under control for the complete picture of this company's asset base.

Annual Net Assets for Digital Aria Co Ltd (2011–2025)

The table below shows the annual net assets of Digital Aria Co Ltd from 2011 to 2025. For live valuation and market cap data, see market value of Digital Aria Co Ltd.

Year Net Assets Change
2025-12-31 ₩173.86 Billion
≈ $117.82 Million
+10.41%
2024-12-31 ₩157.46 Billion
≈ $106.71 Million
-8.19%
2023-12-31 ₩171.52 Billion
≈ $116.24 Million
+46.96%
2022-12-31 ₩116.71 Billion
≈ $79.09 Million
-1.66%
2021-12-31 ₩118.68 Billion
≈ $80.43 Million
+32.82%
2020-12-31 ₩89.35 Billion
≈ $60.55 Million
+39.75%
2019-12-31 ₩63.94 Billion
≈ $43.33 Million
-6.89%
2018-12-31 ₩68.66 Billion
≈ $46.53 Million
+78.61%
2017-12-31 ₩38.44 Billion
≈ $26.05 Million
+13.47%
2016-12-31 ₩33.88 Billion
≈ $22.96 Million
+12.62%
2015-12-31 ₩30.08 Billion
≈ $20.39 Million
+33.60%
2014-12-31 ₩22.52 Billion
≈ $15.26 Million
+116.95%
2013-12-31 ₩10.38 Billion
≈ $7.03 Million
-26.33%
2012-12-31 ₩14.09 Billion
≈ $9.55 Million
-23.35%
2011-12-31 ₩18.38 Billion
≈ $12.46 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Digital Aria Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1059729341000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings ₩10.60 Billion 7.05%
Other Components ₩139.66 Billion 92.95%
Total Equity ₩150.25 Billion 100.00%

Digital Aria Co Ltd Competitors by Market Cap

The table below lists competitors of Digital Aria Co Ltd ranked by their market capitalization.

Company Market Cap
VietinBank Securities JSC
VN:CTS
$210.92 Million
Shanghai Jinqiao Export Processing Zone Development Co Ltd B
SHG:900911
$210.94 Million
Selan Exploration Technology Limited
NSE:SELAN
$210.95 Million
Chicago Atlantic BDC, Inc.
NASDAQ:LIEN
$211.09 Million
SHANGH.DAZ.PUBL.UTIL.YC 1
F:6WL
$210.87 Million
Heron Therapeuti
NASDAQ:HRTX
$210.87 Million
Sierra Madre Gold and Silver Ltd
V:SM
$210.82 Million
Hathway Cable & Datacom Limited
NSE:HATHWAY
$210.76 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Digital Aria Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 157,464,523,720 to 150,253,579,570, a change of -7,210,944,150 (-4.6%).
  • Net loss of 9,226,687,730 reduced equity.
  • Share repurchases of 354,550,710 reduced equity.
  • New share issuances of 40,230,000 increased equity.
  • Other factors increased equity by 2,330,064,290.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ₩-9.23 Billion -6.14%
Share Repurchases ₩354.55 Million -0.24%
Share Issuances ₩40.23 Million +0.03%
Other Changes ₩2.33 Billion +1.55%
Total Change ₩- -4.58%

Book Value vs Market Value Analysis

This analysis compares Digital Aria Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.07x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.22x to 2.07x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 ₩1587.90 ₩3530.00 x
2017-12-31 ₩1684.07 ₩3530.00 x
2018-12-31 ₩2839.43 ₩3530.00 x
2019-12-31 ₩2588.35 ₩3530.00 x
2020-12-31 ₩3354.02 ₩3530.00 x
2021-12-31 ₩1847.92 ₩3530.00 x
2022-12-31 ₩1842.27 ₩3530.00 x
2023-12-31 ₩2124.29 ₩3530.00 x
2024-12-31 ₩1880.38 ₩3530.00 x
2025-12-31 ₩1704.42 ₩3530.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Digital Aria Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -6.14%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -13.26%
  • • Asset Turnover: 0.30x
  • • Equity Multiplier: 1.52x
  • Recent ROE (-6.14%) is above the historical average (-11.13%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 -7.22% -9.13% 0.30x 2.63x ₩-3.84 Billion
2015 -14.30% -25.63% 0.33x 1.67x ₩-7.31 Billion
2016 -15.35% -29.36% 0.34x 1.52x ₩-8.59 Billion
2017 -12.53% -28.08% 0.27x 1.63x ₩-8.66 Billion
2018 6.66% 10.50% 0.40x 1.57x ₩-2.29 Billion
2019 -25.69% -27.85% 0.42x 2.18x ₩-22.82 Billion
2020 -18.92% -39.37% 0.35x 1.36x ₩-25.84 Billion
2021 -14.49% -39.46% 0.23x 1.60x ₩-29.07 Billion
2022 -9.73% -23.59% 0.26x 1.61x ₩-23.02 Billion
2023 -1.43% -4.38% 0.26x 1.25x ₩-18.35 Billion
2024 -14.47% -41.49% 0.25x 1.40x ₩-38.54 Billion
2025 -6.14% -13.26% 0.30x 1.52x ₩-24.25 Billion

Industry Comparison

This section compares Digital Aria Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $368,573,438,392
  • Average return on equity (ROE) among peers: 0.96%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Digital Aria Co Ltd (115450) ₩173.86 Billion -7.22% 0.32x $210.89 Million
ORIENTBIO Inc. (002630) $57.60 Billion 0.00% 0.70x $43.15 Million
Green Cross (005250) $1.51 Trillion 0.20% 0.84x $425.10 Million
Green Cross Holdings Preference Shares (005257) $1.85 Trillion 1.30% 0.98x $3.74 Million
Pharmicell (005690) $51.52 Billion 8.44% 0.23x $736.42 Million
GeneOne Life Science Inc (011000) $39.74 Billion 0.00% 0.49x $49.94 Million
HLB Co. Ltd (028300) $19.44 Billion 0.00% 0.66x $5.41 Billion
Daesung Microbiological Labs. Co. Ltd (036480) $37.00 Billion 2.34% 0.69x $19.29 Million
Seoulin Bioscience Co.Ltd (038070) $51.49 Billion 4.00% 0.38x $37.92 Million
Hyundai Bioscience Co. Ltd (048410) $58.24 Billion 3.27% 0.77x $872.13 Million
iNtRON Biotechnology Inc (048530) $11.93 Billion -9.93% 0.65x $77.34 Million

About Digital Aria Co Ltd

KQ:115450 Korea Biotechnology
Market Cap
$210.89 Million
₩311.19 Billion KRW
Market Cap Rank
#16334 Global
#675 in Korea
Share Price
₩3530.00
Change (1 day)
+1.29%
52-Week Range
₩2545.00 - ₩9560.00
All Time High
₩25764.90
About

HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more